11 Systemic disease is linked to autoimmune dysfunction that may eventually become irreversible
Gallbladder-Related Tests: Semaglutide carries a risk of gallbladder disease, including cholelithiasis and cholecystitis, which may affect liver function tests (particularly bilirubin and alkaline phosphatase)
Who qualifies for Tirzepatide injections for weight loss
This guide is organized so you can either read it end to end or jump to the number you need: the at-a-glance table first, then composition, the exact dosing protocol, the reconstitution math worked step by step, a weekly grid, the phased cycle, a research-framed timeline, stacking logic, troubleshooting, side effects, safety, storage, an honest read of the evidence, and a 15-question FAQ
Retatrutide's own published trials, the Phase 2 study in the New England Journal of Medicine and the Phase 3 TRIUMPH-1 results released in May 2026, did not list hair loss or alopecia among the reported side effects